创新转化
【爱尔成果转化办公室】隶属于爱尔眼科医院集团，负责爱尔眼科医院集团的知识产权资产管理及眼科领域创新成果转化与孵化。【爱尔成果转化办公室】的使命是鼓励有效的眼科创新成果转化，以造福患者，并促进科研和教育。
【爱尔成果转化办公室】接收来自爱尔及社会各方的知识产权信息。【爱尔成果转化办公室】评估这些知识产权的商业化可行性，并在可行的情况下将其授权给产业方或是独立孵化。如果知识产权成功进行授权，知识产权所有者及发明人将获得授权所得。如果知识产权成功独立孵化，知识产权所有者及发明人将获得相应股份。
【爱尔成果转化办公室】会与发明团队一起探讨其知识产权的潜在应用。然后，【爱尔成果转化办公室】结合技术和市场风险，制定转化或孵化策略。【爱尔成果转化办公室】将找到可能对该知识产权感兴趣的公司或投资方，并通过签订许可或投资协议完成创新成果转化与孵化。
Introduction:
AIER Innovation Incubation Office is affiliated with
AIER Eye Hospital Group, responsible for managing AIER’s IP assets and facilitating
innovation incubation and investment in ophthalmology
field. Our mission is to promote effective incubation and investment of
ophthalmic innovations, benefiting patients and advancing scientific research
and education.
We welcome IP disclosures from both AIER and the public.
Our evaluation process assesses commercial viability of these IP rights, which may
be licensed out or incubated independently if deemed feasible. IP owners and
inventors will receive rewards upon successful licensing or corresponding
shares if independently incubated.
In collaboration with inventors, we explore potential
applications of these IP rights. Subsequently, we formulate incubation or
investment strategies based on the risks associated with technology and the
market. Our efforts involve identifying companies or investors interested in
these IPs, boosting the transformation and incubation of innovation through the
signing of license or investment agreements.
